To test the possible functional significance of the Pygo2 overexpression and coexpression with β-catenin in lung cancer, shRNA and stable transfection methods were used to knockdown endogenous Pygo2 expression in two lung cancer cell lines expressing the gene. The gene discussed is PYGO2; the disease is lung carcinoma.